Skip to content

Read Dutch instructions

Read Dutch instructions

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2017-001382-24-NL
Enrollment
170
Registered
2017-06-01
Start date
2017-08-15
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Read Dutch instructions.

Interventions

Trade Name: Ventolin 100 Inhalator CFK-vrij, aërosol, suspensie 100 microgram/dosis Pharmaceutical Form: Inhalation powder

Sponsors

Hagaziekenhuis
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Read Dutch instructions Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 170 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Read Dutch instructions

Design outcomes

Primary

MeasureTime frame
Main Objective: Read Dutch instructions;Secondary Objective: Read Dutch instructions;Primary end point(s): Read Dutch instructions;Timepoint(s) of evaluation of this end point: Read Dutch instructions

Secondary

MeasureTime frame
Secondary end point(s): Read Dutch instructions;Timepoint(s) of evaluation of this end point: Read Dutch instructions.

Countries

Netherlands

Contacts

Public ContactS. Caron

Hagaziekenhuis

S.Caron@hagaziekenhuis.nl+310702102076

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026